Anderson Robert Eugene Jr has made a notable investment in Filana Therapeutics, Inc. by acquiring 19,000 shares of the company’s common stock. The shares were purchased at a price of $0.52 each on November 18, 2026. This acquisition brings Anderson's total ownership to 27,600 shares.

This move is significant as it demonstrates Anderson's confidence in the company’s future prospects. Filana Therapeutics operates within the pharmaceutical preparations sector, which is characterized by ongoing innovation and competition.

Background

Filana Therapeutics, Inc. is based in Austin, Texas, and is classified under the pharmaceutical preparations industry. The company was formerly known as Cassava Sciences Inc, having changed its name in March 2019. Filana is listed under the Central Index Key 0001069530.

What the Filing Says

The SEC filing indicates that Anderson acquired the shares on November 18, 2026, under the transaction code 'P', which signifies a purchase. Following this transaction, Anderson now owns a total of 27,600 shares directly.

Impact

This acquisition may affect Filana Therapeutics' market perception, as insider purchases often suggest confidence in the company's direction. While the filing does not specify any immediate implications for other stakeholders, such transactions can influence investor sentiment and market dynamics.

What's Next

The filing does not say what happens next.